BioCentury
ARTICLE | Company News

Ferring, Intralytix deal

January 13, 2017 7:55 PM UTC

Ferring and Intralytix partnered to develop and commercialize bacteriophage therapies targeting microbiome dysbiosis of the female reproductive tract, oral cavity and skin. The partners entered a sepa...